Work

Phase I trial of the combination of selinexor (SEL), liposomal doxorubicin (DOX) and dexamethasone (Dex) for relapsed and refractory multiple myeloma (RRMM).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.8013

Authors: Rachid C. Baz, Kenneth H. Shain, Melissa Alsina, Jason Brayer, Tami Rashal, Jennifer L Cooksey, Joel G Turner, Jana Dawson, Daniel Sullivan

Institutions: Moffitt Cancer Center, Tel Aviv Sourasky Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2892274908

Cites:

Cited by: 12

Related to: 10